BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38584112)

  • 21. Depletion of Igfbp7 alleviates zebrafish NAFLD progression through inhibiting hepatic ferroptosis.
    Wang Y; Bo J; Zhao Z; Han Y; Zhang Q; Liu L
    Life Sci; 2023 Nov; 332():122086. PubMed ID: 37714372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ferroptosis, a new pathogenetic mechanism in cardiometabolic diseases and cancer: Is there a role for statin therapy?
    Sahebkar A; Foroutan Z; Katsiki N; Jamialahmadi T; Mantzoros CS
    Metabolism; 2023 Sep; 146():155659. PubMed ID: 37442270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Powering the powerhouse: Heme oxygenase-1 regulates mitochondrial function in non-alcoholic fatty liver disease (NAFLD).
    Hinds TD; Stec DE; Tiribelli C
    Acta Physiol (Oxf); 2023 Mar; 237(3):e13931. PubMed ID: 36622267
    [No Abstract]   [Full Text] [Related]  

  • 24. Melatonin Ameliorates Hepatic Ferroptosis in NAFLD by Inhibiting ER Stress via the MT2/cAMP/PKA/IRE1 Signaling Pathway.
    Guan Q; Wang Z; Hu K; Cao J; Dong Y; Chen Y
    Int J Biol Sci; 2023; 19(12):3937-3950. PubMed ID: 37564204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TRIM59 promotes steatosis and ferroptosis in non-alcoholic fatty liver disease via enhancing GPX4 ubiquitination.
    Zhang J; Xie H; Yao J; Jin W; Pan H; Pan Z; Xie D; Xie D
    Hum Cell; 2023 Jan; 36(1):209-222. PubMed ID: 36417114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of ferroptosis in metabolic diseases.
    Xie L; Fang B; Zhang C
    Biochim Biophys Acta Mol Cell Res; 2023 Aug; 1870(6):119480. PubMed ID: 37127193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ferroptosis as a new therapeutic opportunity for nonviral liver disease.
    Jia M; Zhang H; Qin Q; Hou Y; Zhang X; Chen D; Zhang H; Chen Y
    Eur J Pharmacol; 2021 Oct; 908():174319. PubMed ID: 34252441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zeaxanthin prevents ferroptosis by promoting mitochondrial function and inhibiting the p53 pathway in free fatty acid-induced HepG2 cells.
    Liu H; Yan J; Guan F; Jin Z; Xie J; Wang C; Liu M; Liu J
    Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Apr; 1868(4):159287. PubMed ID: 36690321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO/SLC7A11 pathway.
    Jiang T; Xiao Y; Zhou J; Luo Z; Yu L; Liao Q; Liu S; Qi X; Zhang H; Hou M; Miao W; Batsaikhan B; Damba T; Liang Y; Li Y; Zhou L
    Redox Biol; 2023 Dec; 68():102963. PubMed ID: 37984229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Programmed Cell-Death by Ferroptosis: Antioxidants as Mitigators.
    Kajarabille N; Latunde-Dada GO
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pivotal role of heme Oxygenase-1 in reversing the pathophysiology and systemic complications of NAFLD.
    Sasson A; Kristoferson E; Batista R; McClung JA; Abraham NG; Peterson SJ
    Arch Biochem Biophys; 2021 Jan; 697():108679. PubMed ID: 33248947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HMOX1 Promotes Ferroptosis Induced by Erastin in Lens Epithelial Cell through Modulates Fe
    Liao S; Huang M; Liao Y; Yuan C
    Curr Eye Res; 2023 Jan; 48(1):25-33. PubMed ID: 36300537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FMO1 Promotes Nonalcoholic Fatty Liver Disease Progression by Regulating PPARĪ± Activation and Inducing Ferroptosis.
    Zou L; Shi Q; Li Y; Yuan Z; Peng L; Lu J; Zhu H; Ma J
    Discov Med; 2023 Aug; 35(177):612-622. PubMed ID: 37553313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Programmed cell death and lipid metabolism of macrophages in NAFLD.
    Xiao Z; Liu M; Yang F; Liu G; Liu J; Zhao W; Ma S; Duan Z
    Front Immunol; 2023; 14():1118449. PubMed ID: 36742318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Dual Role of Heme Oxygenase-1 in Cancer Cells.
    Chiang SK; Chen SE; Chang LC
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30583467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective autophagy associated with iron overload aggravates non-alcoholic steatohepatitis via ferroptosis.
    Honma K; Kirihara S; Nakayama H; Fukuoka T; Ohara T; Kitamori K; Sato I; Hirohata S; Fujii M; Yamamoto S; Ran S; Watanabe S
    Exp Biol Med (Maywood); 2023 Jul; 248(13):1112-1123. PubMed ID: 37646078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-29a-3p in Exosomes from Heme Oxygenase-1 Modified Bone Marrow Mesenchymal Stem Cells Alleviates Steatotic Liver Ischemia-Reperfusion Injury in Rats by Suppressing Ferroptosis via Iron Responsive Element Binding Protein 2.
    Li X; Wu L; Tian X; Zheng W; Yuan M; Tian X; Zuo H; Song H; Shen Z
    Oxid Med Cell Longev; 2022; 2022():6520789. PubMed ID: 35720183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of free heme-catalyzed Fenton-like reaction prevents non-alcoholic fatty liver disease by hepatocyte-targeted hydrogen delivery.
    Zhao M; Jin Z; Xia C; Chen S; Zeng L; Qin S; He Q
    Biomaterials; 2023 Oct; 301():122230. PubMed ID: 37418855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The multifaceted role of ferroptosis in liver disease.
    Chen J; Li X; Ge C; Min J; Wang F
    Cell Death Differ; 2022 Mar; 29(3):467-480. PubMed ID: 35075250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Research and Progress of Probucol in Nonalcoholic Fatty Liver Disease.
    Chen KQ; Ke BY; Cheng L; Guan MT; Wang ZB; Wang SZ
    Mini Rev Med Chem; 2023; 23(19):1905-1911. PubMed ID: 36967462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.